Prevention of Adverse Drug Reactions in Hospitalized Older Patients with Multi-morbidity and Polypharmacy : the SENATOR randomized controlled clinical trial
Citation
O’Mahony , D , Gudmundsson , A , Soiza , R L , Petrovic , M , Jose Cruz-Jentoft , A , Cherubini , A , Fordham , R , Byrne , S , Dahly , D , Gallagher , P , Lavan , A , Curtin , D , Dalton , K , Cullinane , S , Flanagan , E , Shiely , F , Samuelsson , Ó , Sverrisdóttir , Á , Subbarayan , S , Vandaele , L , Meireson , E , Montero-Errasquín , B , Rexach-Cano , A , Correa-Pérez , A , Lozano-Montoya , I , Vélez-Díaz-Pallarés , M , Cerenzia , A , Corradi , S , Soledad Cotorruelo Ferreiro , M , Dimitri , F , Marinelli , P , Martelli , G , Fong Soe Khioe , R & Eustace , J 2020 , ' Prevention of Adverse Drug Reactions in Hospitalized Older Patients with Multi-morbidity and Polypharmacy : the SENATOR randomized controlled clinical trial ' , Age and Ageing , vol. 49 , no. 4 , pp. 605-614 . https://doi.org/10.1093/ageing/afaa072
Rights
This is a pre-copyedited, author-produced version of an article accepted for publication in Age and Ageing following peer review. The version of record O'Mahony etal. Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trial, Age and Ageing, Volume 49, Issue 4, July 2020, Pages 605–614, is available online at: https://doi.org/10.1093/ageing/afaa072.